When it comes to finding real-life images to facilitate education and practice in dermatology, oncodermatology, and beyond, VisualDx is a key resource. This database provides not only clinical summaries but a wealth of diagrams and photographs and it continues to constantly expand its content.

In the latest update, there are hundreds of new hair and scalp images for conditions such as traction alopecia, psoriasis, and many more, along with improved illustrations for diagnoses like third nerve palsy. There is also additional information on cutaneous adverse effects of immune checkpoint inhibitors and new diagnoses such as functional dyspepsia and dermatitis cruris pustulosa et atrophicans. Finally, VisualDx has recently introduced refreshed patient handouts for diseases like osteomyelitis, Zika virus infection, and hidradenitis suppurativa.

Updated content is not the only thing that is new from VisualDx. There will soon be a new VisualDx 8 app available to support identification of cutaneous conditions on the go. You can use it to look up a specific disease or build a differential based on patient and clinical characteristics. An advance look at the revamped app is available at: app.visualdx.com (you will need to sign in to your VisualDx account).
VisualDx
$15.00 – $18.00Price range: $15.00 through $18.00
𝗦𝗶𝗺𝗽𝗹𝗲 & 𝗘𝗮𝘀𝘆 𝗦𝘁𝗲𝗽
👉We will provide u direct ID(email & password) for login.
👉Can renew with us
✔️Not APK file
✔️All premium access warranty
✔️Delivery within 24 hours Genuine Warranty
𝗪𝗵𝘆 𝗕𝘂𝘆 𝗙𝗿𝗼𝗺 𝗨𝘀 :
✔️Excellent after-sales services
✔️Warranty provided with replacement if not working
SKU: N/A
Category: Medical Software
| Duration | 1year |
|---|---|
| Type | Webproxy, App |
Be the first to review “VisualDx” Cancel reply
Related products
Medical Software
$15.00
Medical Software
$15.00
Medical Software
$5.00
Medical Software
$15.00
Medical Software
$13.00
Medical Software
$15.00
Medical Software
$15.00
Rated 5.00 out of 5
$6.00 – $15.00Price range: $6.00 through $15.00











Reviews
There are no reviews yet.